Zoledronate treatment exerts sex-independent effects on bone and dental physicochemical properties in mice jaw necrosis
Authors:
- Maria Elisa Quezado Lima-VerdeMLMaria Elisa Quezado Lima-Verde
- Maria Imaculada de Queiroz RodriguesMRMaria Imaculada de Queiroz Rodrigues
- Basílio Rodrigues VieiraBVBasílio Rodrigues Vieira
- Francisco Tarcísio Guedes Lima-Verde NetoFNFrancisco Tarcísio Guedes Lima-Verde Neto
- Enzo Victorino Hernandez AgressottEAEnzo Victorino Hernandez Agressott
- Frederico Barbosa de SousaFSFrederico Barbosa de Sousa
- Alexandre Rocha PaschoalAPAlexandre Rocha Paschoal
- Paulo Goberlânio de Barros SilvaPSPaulo Goberlânio de Barros Silva
- Fabrício Bitu SousaFSFabrício Bitu Sousa
- Mário Rogério Lima MotaMMMário Rogério Lima Mota
- Ana Paula Negreiros Nunes AlvesAAAna Paula Negreiros Nunes Alves
- 7 September 2023
- journal article
- research article
- Published by Springer Nature in Journal of Bone and Mineral Metabolism
- Vol. 41 (6) , 760-771
Abstract
Introduction Bisphosphonate (BF) therapy is strongly related to the occurrence of medication-related osteonecrosis of the jaw (ONJ). However, no previous study has evaluated if there are sex-related differences on the ONJ establishment together with bone biomechanical alterations, and if they could have a synergy with the ZA treatment. Materials and Methods This study aimed to analyze the physicochemical properties of mineralized tissues in a zoledronate (ZA)-related osteonecrosis mouse model, by a 2 × 2-factorial design, considering sex (female/male) and treatment (ZA/Saline) factors (n = 8/group). After three ZA (1.0 mg/kg) or saline administrations (days 0, 7, 14), the lower left second molar was extracted (day 42). Further ZA administration (day 49) and euthanasia (day 70) were conducted. After confirmation of ZA-induced jaw necrosis (histologic and microtomographic analysis), spectroscopic and mechanical parameters were assessed. Results ZA-treated groups presented lower bone density due to impaired healing of tooth extraction socket. Sex-related alterations were also observed, with lower bone density in females. Regarding biomechanical parameters, sex and treatment exerted independent influences. ZA, although decreasing flexural modulus and yield stress, increases stiffness mainly due to a higher bone volume. Females show less resistance to higher loads compared to males (considering dimension-independent parameters). Additionally, ZA increases crystallinity in bone and dental structure (p < 0.05). In summary, although strongly related to osteonecrosis occurrence, ZA modifies bone and dental mineral matrix, improving bone mechanical properties. Conclusion Despite sex-dependent differences in bone biomechanics and density, osteonecrosis was established with no sex influence. No synergistic association between sex and treatment factors was observed in this study.Keywords
Funding Information
- Coordination of Superior Level Staff Improvement
- National Council for Scientific and Technological Development
This publication has 40 references indexed in Scilit:
- Tooth dentin defects reflect genetic disorders affecting bone mineralizationBone, 2012
- Molecular interactions between zoledronic acid and bone: An in vitro Raman microspectroscopic studyBone, 2010
- Age-Related Changes in Bone Structure and Strength in Female and Male BALB/c MiceCalcified Tissue International, 2010
- Longitudinal Cohort Study of Risk Factors in Cancer Patients of Bisphosphonate-Related Osteonecrosis of the JawJournal of Clinical Oncology, 2009
- High-Dose Zoledronic Acid Impacts Bone Remodeling with Effects on Osteoblastic Lineage and Bone Mechanical PropertiesClinical Cancer Research, 2009
- Bisphosphonate administration prior to tooth extraction delays initial healing of the extraction socket in ratsJournal of Bone and Mineral Metabolism, 2009
- Biodistribution and Plasma Protein Binding of Zoledronic AcidDrug Metabolism and Disposition, 2008
- Sex Differences of Human Trabecular Bone Microstructure in Aging Are Site-DependentJournal of Bone and Mineral Research, 2007
- Bisphosphonates: Mode of Action and PharmacologyPediatrics, 2007
- Bone biomechanical properties in LRP5 mutant miceBone, 2004